Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGB Atlantic Gold	C$2.92 +∞	C$2.92	C$1.40 ▼ C$2.92	C$690.60M	N/A	620,158 shs	810,251 shs
EQX Equinox Gold	$5.91 +0.5%	$6.52	$4.48 ▼ $7.45	$2.68B	1.17	7.49 million shs	15.58 million shs
KNT K92 Mining Inc. (KNT.V)	C$7.99	C$7.99	C$1.55 ▼ C$8.50	C$1.63B	N/A	1.13 million shs	337,797 shs
TXG 10x Genomics	$11.70 +0.3%	$9.29	$6.78 ▼ $24.76	$1.44B	1.99	2.62 million shs	4.66 million shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGB Atlantic Gold	0.00%	0.00%	0.00%	0.00%	0.00%
EQX Equinox Gold	+0.51%	-5.14%	-11.13%	-13.97%	+11.30%
KNT K92 Mining Inc. (KNT.V)	0.00%	0.00%	0.00%	0.00%	0.00%
TXG 10x Genomics	+0.34%	+7.64%	+36.20%	+27.73%	-40.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AGB Atlantic Gold	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EQX Equinox Gold	3.5367 of 5 stars	3.3	2.0	0.0	0.0	2.6	0.0	3.8
KNT K92 Mining Inc. (KNT.V)	1.7661 of 5 stars	3.4	0.0	0.0	0.0	1.9	0.8	0.6
TXG 10x Genomics	4.3773 of 5 stars	4.2	1.0	0.0	4.8	2.2	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGB Atlantic Gold	0.00	N/A	N/A	N/A
EQX Equinox Gold	2.67	Moderate Buy	$35.00	492.22% Upside
KNT K92 Mining Inc. (KNT.V)	2.80	Moderate Buy	C$14.68	83.67% Upside
TXG 10x Genomics	2.43	Hold	$14.96	27.88% Upside

Current Analyst Ratings Breakdown

Latest AGB, EQX, KNT, and TXG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/26/2025	TXG 10x Genomics	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$12.00 ➝ $13.00
6/24/2025	TXG 10x Genomics	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$12.00 ➝ $13.00
6/23/2025	KNT K92 Mining Inc. (KNT.V)	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	C$17.00 ➝ C$18.00
6/18/2025	EQX Equinox Gold	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
6/13/2025	EQX Equinox Gold	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
6/13/2025	EQX Equinox Gold	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
6/11/2025	TXG 10x Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)
6/3/2025	KNT K92 Mining Inc. (KNT.V)	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform	C$16.00 ➝ C$18.00
5/24/2025	TXG 10x Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)
5/19/2025	TXG 10x Genomics	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$26.00 ➝ $18.00
5/15/2025	TXG 10x Genomics	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$14.00 ➝ $14.00

(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGB Atlantic Gold	C$145.84M	4.74	C$0.15 per share	19.21	C$0.68 per share	4.32
EQX Equinox Gold	$1.51B	1.78	$0.71 per share	8.38	$7.46 per share	0.79
KNT K92 Mining Inc. (KNT.V)	C$144.51M	11.29	C$0.19 per share	42.50	C$0.75 per share	10.65
TXG 10x Genomics	$610.78M	2.36	N/A	N/A	$5.81 per share	2.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGB Atlantic Gold	N/A	C$0.13	22.77	∞	N/A	N/A	N/A	N/A	N/A
EQX Equinox Gold	$339.29M	$0.54	11.82	5.05	N/A	13.96%	2.20%	1.08%	8/6/2025 (Estimated)
KNT K92 Mining Inc. (KNT.V)	N/A	C$0.25	32.48	∞	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	-$182.63M	-$1.30	N/A	N/A	N/A	-25.14%	-23.22%	-18.02%	8/6/2025 (Estimated)

Latest AGB, EQX, KNT, and TXG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/8/2025	Q1 2025	TXG 10x Genomics	-$0.45	-$0.36	+$0.09	-$0.28	$131.91 million	$154.88 million
5/7/2025	Q1 2025	EQX Equinox Gold	$0.11	-$0.08	-$0.19	N/A	$404.00 million	$423.72 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGB Atlantic Gold	N/A	N/A	N/A	N/A	N/A
EQX Equinox Gold	N/A	N/A	N/A	N/A	N/A
KNT K92 Mining Inc. (KNT.V)	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGB Atlantic Gold	73.79	2.99	2.03
EQX Equinox Gold	0.38	0.85	0.50
KNT K92 Mining Inc. (KNT.V)	4.93	3.25	2.43
TXG 10x Genomics	N/A	5.37	4.68

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AGB Atlantic Gold	N/A
EQX Equinox Gold	38.85%
KNT K92 Mining Inc. (KNT.V)	N/A
TXG 10x Genomics	84.68%

Insider Ownership

Company	Insider Ownership
AGB Atlantic Gold	N/A
EQX Equinox Gold	8.35%
KNT K92 Mining Inc. (KNT.V)	N/A
TXG 10x Genomics	9.39%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AGB Atlantic Gold	N/A	236.91 million	N/A	Not Optionable
EQX Equinox Gold	3,692	456.15 million	418.06 million	Not Optionable
KNT K92 Mining Inc. (KNT.V)	N/A	204.20 million	N/A	Not Optionable
TXG 10x Genomics	1,240	123.13 million	111.57 million	Optionable

AGB, EQX, KNT, and TXG Headlines

Recent News About These Companies

Bank of America Issues Positive Forecast for 10x Genomics (NASDAQ:TXG) Stock Price

3 hours ago | americanbankingnews.com

10x Genomics (NASDAQ:TXG) Trading 7.3% Higher Following Analyst Upgrade

3 hours ago | americanbankingnews.com

Bank of America Forecasts Strong Price Appreciation for 10x Genomics (NASDAQ:TXG) Stock

June 26 at 2:11 PM | marketbeat.com

Barclays Forecasts Strong Price Appreciation for 10x Genomics (NASDAQ:TXG) Stock

June 26 at 2:13 AM | americanbankingnews.com

10x Genomics (NASDAQ:TXG) Trading Up 7.3% Following Analyst Upgrade

June 25 at 4:08 PM | marketbeat.com

10x Genomics (NASDAQ:TXG) Given New $13.00 Price Target at Barclays

June 24 at 11:21 AM | marketbeat.com

10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Brokerages

June 24 at 3:01 AM | americanbankingnews.com

10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by Analysts

June 24 at 2:59 AM | marketbeat.com

10x Genomics: Stuck In Neutral

June 23, 2025 | seekingalpha.com

10x Genomics Settles Patent Dispute With Bruker

June 23, 2025 | insidermonkey.com

GAMMA Investing LLC Has $273,000 Holdings in 10x Genomics (NASDAQ:TXG)

June 22, 2025 | marketbeat.com

Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know

June 17, 2025 | msn.com

10x Genomics, Inc. (NASDAQ:TXG) Stock Position Decreased by Assenagon Asset Management S.A.

June 14, 2025 | marketbeat.com

Weiss Ratings Reaffirms "Sell (E+)" Rating for 10x Genomics (NASDAQ:TXG)

June 12, 2025 | marketbeat.com

Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns

June 10, 2025 | msn.com

TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions

June 10, 2025 | msn.com

10x Genomics (NASDAQ:TXG) Stock Price Up 8% - Time to Buy?

June 9, 2025 | marketbeat.com

10x Genomics (NASDAQ:TXG) Trading Down 4.6% - What's Next?

June 3, 2025 | marketbeat.com

Jefferies Financial Group Inc. Lowers Holdings in 10x Genomics, Inc. (NASDAQ:TXG)

June 1, 2025 | marketbeat.com

10x Genomics, Inc. (NASDAQ:TXG) Given Average Recommendation of "Hold" by Analysts

May 31, 2025 | marketbeat.com

10x Genomics (NASDAQ:TXG) Trading Up 4.2% - Still a Buy?

May 30, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGB, EQX, KNT, and TXG Company Descriptions

Atlantic Gold CVE:AGB

C$2.92 +2.92 (+∞)

As of 07/18/2019

Atlantic Gold Corporation engages in the acquisition, exploration, and development of gold properties in Canada. It holds 63.2% effective ownership interests in the Touquoy gold project covering approximately 1,760 hectares; and 100% interest in the Beaver Dam gold, Cochrane Hill, and Fifteen Mile Stream projects located in Nova Scotia. The company was formerly known as Spur Ventures Inc. and changed its name to Atlantic Gold Corporation in August 2014. Atlantic Gold Corporation is based in Vancouver, Canada.

Equinox Gold NYSEAMERICAN:EQX

$5.91 +0.03 (+0.51%)

Closing price 06/26/2025 04:10 PM Eastern

Extended Trading

$5.84 -0.07 (-1.10%)

As of 05:05 AM Eastern

Equinox Gold Corp. engages in the exploration, acquisition, development, and operation of mineral properties in the Americas. It explores gold and silver deposits. It holds interest in properties in California located in the United States; Guerrero State located in Mexico; Maranhão, Bahia, and Mina Gerais state located in Brazil; and Ontario, Canada. The company was formerly known as Trek Mining Inc. and changed its name to Equinox Gold Corp. in December 2017. Equinox Gold Corp. was incorporated in 2007 and is headquartered in Vancouver, Canada.

K92 Mining Inc. (KNT.V) CVE:KNT

C$7.99 0.00 (0.00%)

As of 12/8/2020

K92 Mining Inc. engages in the mining, exploration, and development of mineral deposits in Papua New Guinea. The company produces gold, copper, and silver. Its principal property is the Kainantu property that covers an area of 725 square kilometers located in the Eastern Highlands province. The company is headquartered in Vancouver, Canada.

10x Genomics NASDAQ:TXG

$11.70 +0.04 (+0.34%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$11.66 -0.04 (-0.34%)

As of 04:19 AM Eastern

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time